130 related articles for article (PubMed ID: 9686938)
1. Characterization of the N-methyl-D-aspartate (NMDA) receptor in the embryonic chick brain.
Jacobsson SO; Hedin H; Sellström A; Fowler CJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):625-33. PubMed ID: 9686938
[TBL] [Abstract][Full Text] [Related]
2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptor binding is altered and seizure potential reduced in pregnant rats.
Standley CA
Brain Res; 1999 Oct; 844(1-2):10-9. PubMed ID: 10536256
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ influx through glutamate receptor-associated channels in retina cells correlates with neuronal cell death.
Ferreira IL; Duarte CB; Carvalho AP
Eur J Pharmacol; 1996 Apr; 302(1-3):153-62. PubMed ID: 8791003
[TBL] [Abstract][Full Text] [Related]
5. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
Prehn JH; Lippert K; Krieglstein J
Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791
[TBL] [Abstract][Full Text] [Related]
6. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
Reynolds IJ
J Neurochem; 1994 Jan; 62(1):54-62. PubMed ID: 7903355
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of cyclopropyl analogues of 2-amino-5-phosphonopentanoic acid.
Dappen MS; Pellicciari R; Natalini B; Monahan JB; Chiorri C; Cordi AA
J Med Chem; 1991 Jan; 34(1):161-8. PubMed ID: 1671413
[TBL] [Abstract][Full Text] [Related]
8. Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats.
Löscher W; Hönack D; Fassbender CP
Neurosci Lett; 1991 Mar; 124(1):115-8. PubMed ID: 1677457
[TBL] [Abstract][Full Text] [Related]
9. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.
Mugnaini M; Meoni P; Bunnemann B; Corsi M; Bowery NG
Br J Pharmacol; 2001 Apr; 132(8):1883-97. PubMed ID: 11309261
[TBL] [Abstract][Full Text] [Related]
12. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Ca2(+)-mobilizing excitatory amino acid receptors in cultured chick cortical cells.
McMillian M; Pritchard GA; Miller LG
Eur J Pharmacol; 1990 Oct; 189(4-5):253-66. PubMed ID: 1980647
[TBL] [Abstract][Full Text] [Related]
14. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
15. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
Laurie DJ; Seeburg PH
Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
[TBL] [Abstract][Full Text] [Related]
16. Activity of ionotropic glutamate receptors in retinal cells: effect of ascorbate/Fe(2+)-induced oxidative stress.
Agostinho P; Duarte CB; Oliveira CR
J Neurochem; 1996 Sep; 67(3):1153-63. PubMed ID: 8752122
[TBL] [Abstract][Full Text] [Related]
17. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
[TBL] [Abstract][Full Text] [Related]
19. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
